MME and ductal breast carcinoma in situ: High CD10 immunostaining (score = 6), similar to that observed in the normal breast tissue, was present in 27% (17/62) of the DCIS samples, whereas 73% (45/62) showed CD10 immunostaining below the levels observed in the normal tissue (score<6) (figure 1.B and 1.C).